66 related articles for article (PubMed ID: 25397469)
1. The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment.
Bernal E; Serrano J; Perez A; Valero S; Garcia E; Marín I; Muñoz A; Verdú JM; Vera C; Cano A
J Int AIDS Soc; 2014; 17(4 Suppl 3):19723. PubMed ID: 25397469
[TBL] [Abstract][Full Text] [Related]
2. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.
Bernal Morell E; Serrano Cabeza J; Muñoz Á; Marín I; Masiá M; Gutiérrez F; Cano A
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):648-53. PubMed ID: 27005326
[TBL] [Abstract][Full Text] [Related]
3. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery.
Serrano-Villar S; Moreno S; Fuentes-Ferrer M; Sánchez-Marcos C; Avila M; Sainz T; de Villar NG; Fernández-Cruz A; Estrada V
HIV Med; 2014 Jan; 15(1):40-9. PubMed ID: 24007533
[TBL] [Abstract][Full Text] [Related]
4. [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].
Ferraro S; Paolillo S; Gargiulo M; Costanzo P; Maggi P; Chirianni A; Chiariello M; Filardi PP
G Ital Cardiol (Rome); 2009 Sep; 10(9):596-601. PubMed ID: 19891251
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
[TBL] [Abstract][Full Text] [Related]
6. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
[TBL] [Abstract][Full Text] [Related]
7. CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk.
Menozzi M; Zona S; Santoro A; Carli F; Stentarelli C; Mussini C; Guaraldi G
J Int AIDS Soc; 2014; 17(4 Suppl 3):19709. PubMed ID: 25397456
[TBL] [Abstract][Full Text] [Related]
8. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
MacArthur RD; Novak RM; Peng G; Chen L; Xiang Y; Hullsiek KH; Kozal MJ; van den Berg-Wolf M; Henely C; Schmetter B; Dehlinger M; ;
Lancet; 2006 Dec; 368(9553):2125-35. PubMed ID: 17174704
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.
Bunupuradah T; Suntarattiwong P; Li A; Sirivichayakul S; Pancharoen C; Boonrak P; Puthanakit T; Kerr SJ; Ruxrungtham K; Chotpitayasunondh T; Hirschel B; Ananworanich J;
Int J Infect Dis; 2010 Apr; 14(4):e311-6. PubMed ID: 19699673
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
11. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
[TBL] [Abstract][Full Text] [Related]
12. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.
D'Abramo A; Zingaropoli MA; Oliva A; D'Agostino C; Al Moghazi S; De Luca G; Iannetta M; Mastroianni CM; Vullo V
Mediators Inflamm; 2014; 2014():192594. PubMed ID: 25374442
[TBL] [Abstract][Full Text] [Related]
13. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
[TBL] [Abstract][Full Text] [Related]
15. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia.
Viskovic K; Zidovec-Lepej S; Gorenec L; Grgic I; Lukas D; Zekan S; Dragobratovic A; Begovac J
J Int AIDS Soc; 2014; 17(4 Suppl 3):19548. PubMed ID: 25394055
[TBL] [Abstract][Full Text] [Related]
17. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; San RJ; Soriano V; Sánchez-Parra C; Sainz T; Fernández-Cruz A
Eur J Prev Cardiol; 2014 Jun; 21(6):739-48. PubMed ID: 22718798
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
20. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
